145 related articles for article (PubMed ID: 6979340)
1. The association of antinuclear antibodies, antilymphocyte antibodies, and C4 activation among the relatives of children with systemic lupus erythematosus.
Lehman TJ; Curd JG; Zvaifler NJ; Hanson V
Arthritis Rheum; 1982 May; 25(5):556-61. PubMed ID: 6979340
[TBL] [Abstract][Full Text] [Related]
2. Serum complement abnormalities in the antinuclear antibody-positive relatives of children with systemic lupus erythematosus.
Lehman TJ; Hanson V; Singsen BH; Kornreich HK; Bernstein B; King KK
Arthritis Rheum; 1979 Sep; 22(9):954-8. PubMed ID: 314291
[TBL] [Abstract][Full Text] [Related]
3. Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus.
Nguyen CP; Cao VV; Fehér J; Gergely P
Acta Med Hung; 1988; 45(2):145-59. PubMed ID: 3266790
[TBL] [Abstract][Full Text] [Related]
4. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.
Davis P; Cumming RH; Verrier-Jones J
Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447
[TBL] [Abstract][Full Text] [Related]
5. Relationship of clinical findings in systemic lupus erythematosus to seroreactivity.
Rothschild BM; Jones JV; Chesney C; Pifer DD; Thompson LD; James KK; Badger H
Arthritis Rheum; 1983 Jan; 26(1):45-51. PubMed ID: 6600613
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to nonhistone nuclear antigens and antilymphocyte antibodies among children and adults with systemic lupus erythematosus and their relatives.
Lehman TJ; Hanson V; Zvaifler N; Sharp G; Alspaugh M
J Rheumatol; 1984 Oct; 11(5):644-7. PubMed ID: 6392551
[TBL] [Abstract][Full Text] [Related]
7. Hypercatabolism of C3 and C4 in active and inactive systemic lupus erythematosus.
Charlesworth JA; Peake PW; Golding J; Mackie JD; Pussell BA; Timmermans V; Wakefield D
Ann Rheum Dis; 1989 Feb; 48(2):153-9. PubMed ID: 2784659
[TBL] [Abstract][Full Text] [Related]
8. Natural cell mediated cytotoxicity in systemic lupus erythematosus: suppression by antilymphocyte antibody.
Goto M; Tanimoto K; Horiuchi Y
Arthritis Rheum; 1980 Nov; 23(11):1274-81. PubMed ID: 6969594
[TBL] [Abstract][Full Text] [Related]
9. Family study of systemic lupus erythematosus: analysis of the clinical history, skin immunofluorescence, and serologic parameters.
Lowenstein MB; Rothfield NF
Arthritis Rheum; 1977; 20(7):1293-1303. PubMed ID: 334183
[TBL] [Abstract][Full Text] [Related]
10. Anti-RNP antibodies are associated with the interferon gene signature but not decreased complement levels in SLE.
Hubbard EL; Pisetsky DS; Lipsky PE
Ann Rheum Dis; 2022 May; 81(5):632-643. PubMed ID: 35115332
[TBL] [Abstract][Full Text] [Related]
11. Systemic lupus erythematosus. Some contemporary laboratory aspects.
Deegan MJ
Arch Pathol Lab Med; 1980 Aug; 104(8):399-404. PubMed ID: 6967303
[TBL] [Abstract][Full Text] [Related]
12. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
[TBL] [Abstract][Full Text] [Related]
13. Progressive reduction of serum complement levels: a risk factor for relapse in patients with hypocomplementemia in systemic lupus erythematosus.
Miyawaki Y; Sada K; Asano Y; Hayashi K; Yamamura Y; Hiramatsu S; Ohashi K; Morishita M; Watanabe H; Matsumoto Y; Kawabata T; Wada J
Lupus; 2018 Nov; 27(13):2093-2100. PubMed ID: 30309286
[TBL] [Abstract][Full Text] [Related]
14. [Components of the classical complement pathway in systemic lupus erythematosus].
Maillet F; Goetz J; Hauptmann G; Clauvel JP; Mery JP; Kahn MF; Kazatchkine M
Presse Med; 1987 Mar; 16(8):378-82. PubMed ID: 2950498
[TBL] [Abstract][Full Text] [Related]
15. Relation between lymphocytotoxic antibodies, anti-DNA antibodies and a common anti-DNA antibody idiotype PR4 in patients with systemic lupus erythematosus, their relatives and spouses.
Le Page SH; Williams W; Parkhouse D; Cambridge G; MacKenzie L; Lydyard PM; Isenberg DA
Clin Exp Immunol; 1989 Sep; 77(3):314-8. PubMed ID: 2805403
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of antilymphocyte antibody in SLE and its correlation with disease activity.
Okudaira K; Tanimoto K; Aikawa T; Horiuchi Y; Aotsuka S
Scand J Rheumatol; 1983; 12(1):21-8. PubMed ID: 6601298
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin class of antilymphocyte antibodies in systemic lupus erythematosus patients and their families.
Searles RP; Husby G; Messner P
Acta Pathol Microbiol Scand C; 1977 Dec; 85C(6):463-8. PubMed ID: 343499
[TBL] [Abstract][Full Text] [Related]
18. Complement fixing immune complexes containing antinuclear antibodies in patients with systemic lupus erythematosus.
Budd JJ; Moore TL; Osborn TG
J Rheumatol; 1988 Feb; 15(2):247-50. PubMed ID: 3258914
[TBL] [Abstract][Full Text] [Related]
19. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.
Lim KL; Jones AC; Brown NS; Powell RJ
Ann Rheum Dis; 1993 Jun; 52(6):429-35. PubMed ID: 8323394
[TBL] [Abstract][Full Text] [Related]
20. Immunological aspects of biopsy-proven lupus nephritis in Bahraini patients with systemic lupus erythematosus.
Farid EM; Hassan AB; Abalkhail AA; El-Agroudy AE; Arrayed SA; Al-Ghareeb SM
Saudi J Kidney Dis Transpl; 2013 Nov; 24(6):1271-9. PubMed ID: 24231503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
